Chorioretinal Degeneration clinical trials at UCSF

1 research study open to eligible people

Chorioretinal degeneration is a condition where the retina and surrounding areas deteriorate. UCSF is conducting research to observe how ornithine levels and genetic factors contribute to this eye disease. These studies aim to track the natural history of retinal changes in affected individuals.

Showing trials for

  • Gyrate Atrophy Ocular and Systemic Study

    open to eligible people ages 12 years and up

    The Gyrate Atrophy Ocular and Systemic Study characterizes the natural history of ornithine levels and retinal degeneration (RD) associated with disease-causing OAT variants in the presence of standard care dietary treatment regimens over 4 years. The research goal is to understand the impact of OAT mutations on plasma ornithine levels and retinal degeneration. Funding Source- FDA OOPD

    San Francisco, California and other locations

Last updated: